Tamra, Jean, Courey. Detection, Prevention, and Management of Extrapyramidal Symptoms. Journal for Nurse Practitioners. 2007;3(7):464-9.

Blair DT, Dauner A. Extrapyramidal symptoms are serious side-effects of antipsychotic and other drugs. The Nurse practitioner. 1992;17(11):56, 62-4, 7.

Burgyone K, Aduri K, Ananth J, Parameswaran S. The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptoms. Current pharmaceutical design. 2004;10(18):2239-48.

Shireen E. Experimental treatment of antipsychotic-induced movement disorders. Journal of experimental pharmacology. 2016;8:1-10.

dyskinesia. Rmdeseat. Available at: www.medicalnewstoday.com Accessed July 18, 2006.

Bailey KP. Do atypical antipsychotic agents cause tardive dyskinesia? Journal of psychosocial nursing and mental health services. 2004;42(10):14-9.

Davis R, Bryson HM. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs. 1994;47(4):677-700.

MacLeod W. Case report: severe neurologic reaction to ciprofloxacin. Canadian family physician Medecin de famille canadien. 2001;47:553-5.

Lee CH, Cheung RT, Chan TM. Ciprofloxacin-induced oral facial dyskinesia in a patient with normal liver and renal function. Hospital medicine (London, England : 1998). 2000;61(2):142-3.

Simpson KJ, Brodie MJ. Convulsions related to enoxacin. Lancet (London, England). 1985;2(8447):161.

Slavich IL, Gleffe RF, Haas EJ. Grand mal epileptic seizures during ciprofloxacin therapy. Jama. 1989;261(4):558-9.

Thomas RJ, Reagan DR. Association of a Tourette-like syndrome with ofloxacin. The Annals of pharmacotherapy. 1996;30(2):138-41.

Singh J, Agarwal AK, Sudrania SP. Extrapyramidal syndrome following ciprofloxacin treatment. Indian pediatrics. 1994;31(5):608-9.

Akahane K, Tsutomi Y, Kimura Y, Kitano Y. Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding. Chemotherapy. 1994;40(6):412-7.

Slobodin G, Elias N, Zaygraikin N, Sheikh-Ahmad M, Sabetay S, Weller B, et al. Levofloxacin-induced delirium. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2009;30(2):159-61.

Zhang LR, Wang YM, Chen BY, Cheng NN. Neurotoxicity and toxicokinetics of norfloxacin in conscious rats. Acta pharmacologica Sinica. 2003;24(6):605-9.

Ball P, Mandell L, Patou G, Dankner W, Tillotson G. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context. International journal of antimicrobial agents. 2004;23(5):421-9.

Pastor P, Moitinho E, Elizalde I, Cirera I, Tolosa E. Reversible oral-facial dyskinesia in a patient receiving ciprofloxacin hydrochloride. Journal of neurology. 1996;243(8):616-7.

De Bleecker JL, Vervaet VL, De Sarro A. Reversible orofacial dyskinesia after ofloxacin treatment. Movement disorders : official journal of the Movement Disorder Society. 2004;19(6):731-2.

Blomer R, Bruch K, Krauss H, Wacheck W. Safety of ofloxacin--adverse drug reactions reported during phase-II studies in Europe and in Japan. Infection. 1986;14 Suppl 4:S332-4.

Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC. Seizures associated with levofloxacin: case presentation and literature review. European journal of clinical pharmacology. 2009;65(10):959-62.

Jungst G, Mohr R. Side effects of ofloxacin in clinical trials and in postmarketing surveillance. Drugs. 1987;34 Suppl 1:144-9.

Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. British journal of clinical pharmacology. 2011;72(3):381-93.

Fennig S, Mauas L. Ofloxacin-induced delirium. The Journal of clinical psychiatry. 1992;53(4):137-8.

Fernandez-Torre JL. Levofloxacin-induced delirium: Diagnostic considerations. Clinical neurology and neurosurgery. 2006;108(6):614.

Lowe MN, Lamb HM. Gemifloxacin. Drugs. 2000;59(5):1137-47; discussion 48.

Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrobial agents and chemotherapy. 1989;33(10):1704-8.

Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, et al. Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrobial agents and chemotherapy. 1988;32(2):190-4.

Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B. Levofloxacin-induced delirium with psychotic features. General hospital psychiatry. 2008;30(4):381-3.